Mark Slee

2016

CSF hypotension: A review of its manifestations, investigation and management

Pattichis, A. & Slee, M., 1 Dec 2016, In: Journal of Clinical Neuroscience. 34, p. 39-43 5 p.

Research output: Contribution to journal › Review article › peer-review

25 Citations (Scopus)

2014

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective part 1 historical and established therapies

Broadley, S., Barnett, M., Boggild, M., Brew, B., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A., Lechner-Scott, J., Macdonell, R., Marriott, M., Mason, D., Parratt, J., Reddel, S., Shaw, C., Slee, M., Spies, J., Taylor, B., Carroll, W., Kilpatrick, T. & 4 others, King, J., McCombe, P., Pollard, J. & Willoughby, E., 1 Nov 2014, In: Journal of Clinical Neuroscience. 21, 11, p. 1835-1846 12 p.

Research output: Contribution to journal › Review article › peer-review

16 Citations (Scopus)

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy

Broadley, S., Barnett, M., Boggild, M., Brew, B., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A., Lechner-Scott, J., Macdonell, R., Marriott, M., Mason, D., Parratt, J., Reddel, S., Shaw, C., Slee, M., Spies, J., Taylor, B., Carroll, W., Kilpatrick, T. & 4 others, King, J., McCombe, P., Pollard, J. & Willoughby, E., 1 Nov 2014, In: Journal of Clinical Neuroscience. 21, 11, p. 1847-1856 10 p.

Research output: Contribution to journal › Review article › peer-review

18 Citations (Scopus)

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations

Broadley, S., Barnett, M., Boggild, M., Brew, B., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A., Lechner-Scott, J., Macdonell, R., Marriott, M., Mason, D., Parratt, J., Reddel, S., Shaw, C., Slee, M., Spies, J., Taylor, B., Carroll, W., Kilpatrick, T. & 4 others, King, J., McCombe, P., Pollard, J. & Willoughby, E., 1 Nov 2014, In: Journal of Clinical Neuroscience. 21, 11, p. 1857-1865 9 p.

Research output: Contribution to journal › Review article › peer-review

13 Citations (Scopus)

2011

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

Patsopoulos, N. A., Bayer Pharma MS Genetics Working Group, Steering Committees of Studies Evaluating IFNβ‐1b and a CCR1‐Antagonist, ANZgene, GeneMSA, International Multiple Sclerosis Genetics Consortium, Esposito, F., Reischl, J., Lehr, S., Bauer, D., Heubach, J., Sandbrink, R., Pohl, C., Edan, G., Kappos, L., Miller, D., Montalbán, J., Polman, C. H., Freedman, M. S., Hartung, H. P. & 57 others, Arnason, B. G. W., Comi, G., Cook, S., Filippi, M., Goodin, D. S., Jeffery, D., O'Connor, P., Ebers, G. C., Langdon, D., Reder, A. T., Traboulsee, A., Zipp, F., Schimrigk, S., Hillert, J., Bahlo, M., Booth, D. R., Broadley, S., Brown, M. A., Browning, B. L., Browning, S. R., Butzkueven, H., Carroll, W. M., Chapman, C., Foote, S. J., Griffiths, L., Kermode, A. G., Kilpatrick, T. J., Lechner-Scott, J., Marriott, M., Mason, D., Moscato, P., Heard, R. N., Pender, M. P., Perreau, V. M., Perera, D., Rubio, J. P., Scott, R. J., Slee, M., Stankovich, J., Stewart, G. J., Taylor, B. V., Tubridy, N., Willoughby, E., Wiley, J., Matthews, P., Boneschi, F. M., Compston, A., Haines, J., Hauser, S. L., McCauley, J., Ivinson, A., Oksenberg, J. R., Pericak-Vance, M., Sawcer, S. J., De Jager, P. L., Hafler, D. A. & de Bakker, P. I. W., 21 Dec 2011, In: Annals of Neurology. 70, 6, p. 897-912 16 p.

Research output: Contribution to journal › Review article › peer-review

267 Citations (Scopus)

Associate Professor Mark Slee

Research output

Search results

CSF hypotension: A review of its manifestations, investigation and management

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective part 1 historical and established therapies

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci